​

Enfusion (ENFN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ENFN Stock Rating

Enfusion stock's rating consensus is Hold, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (28.57%), 3 Hold (42.86%), 2 Sell (28.57%), and 0 Strong Sell (0.00%).

Hold
Total 7 0 2 3 2 Strong Sell Sell Hold Buy Strong Buy

ENFN Price Target Upside V Benchmarks

TypeNameUpside
StockEnfusion-
SectorTechnology Stocks 9.00%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$10.76$10.76$10.76
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25--6--6
Mar, 25--6--6
Feb, 25--6--6
Jan, 25126-312
Dec, 24123-39
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 28, 2024Goldman SachsSelldowngrade
Jan 03, 2023Morgan StanleyOverweightupgrade

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 $1 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-4.30$-0.16$0.10$0.02--
Avg Forecast$-0.24$0.09$0.15$0.21$0.29$0.38
High Forecast$-0.24$0.09$0.15$0.23$0.34$0.57
Low Forecast$-0.25$0.09$0.15$0.18$0.20$0.26
Surprise %1691.67%-277.78%-33.33%-90.48%--

Revenue Forecast

$100M $140M $180M $220M $260M $300M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$111.70M$150.35M$174.53M$201.61M--
Avg Forecast$110.07M$149.82M$173.33M$202.83M$237.54M$278.43M
High Forecast$111.83M$151.59M$174.09M$204.06M$240.65M$278.75M
Low Forecast$108.31M$147.37M$172.26M$201.52M$234.02M$278.11M
Surprise %1.48%0.35%0.70%-0.60%--

Net Income Forecast

$-300M $-220M $-140M $-60M $20M $100M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-282.24M$-13.26M$6.03M$2.82M--
Avg Forecast$-31.36M$11.33M$19.29M$26.67M$34.70M$38.58M
High Forecast$-30.71M$11.50M$19.77M$29.77M$43.37M$74.32M
Low Forecast$-32.01M$11.08M$18.81M$23.57M$26.03M$34.24M
Surprise %799.95%-217.11%-68.77%-89.41%--

ENFN Forecast FAQ

Is Enfusion stock a buy?

Enfusion stock has a consensus rating of Hold, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 3 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Enfusion is a neutral investment for most analysts.

What is Enfusion's price target?

Enfusion's price target, set by 7 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $10.76.

How does Enfusion stock forecast compare to its benchmarks?

Enfusion's stock forecast shows a 0% downside, underperforming the average forecast for the technology stocks sector (9.00%).

What is the breakdown of analyst ratings for Enfusion over the past three months?

  • April 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Enfusion’s EPS forecast?

Enfusion's average annual EPS forecast for its fiscal year ending in December 2025 is $0.29, marking a 1350.00% increase from the reported $0.02 in 2024. Estimates for the following years are.

What is Enfusion’s revenue forecast?

Enfusion's average annual revenue forecast for its fiscal year ending in December 2025 is $237.54M, reflecting a 17.82% increase from the reported $201.61M in 2024. The forecast for.

What is Enfusion’s net income forecast?

Enfusion's net income forecast for the fiscal year ending in December 2025 stands at $34.7M, representing an 1129.19% increase from the reported $2.82M in 2024. Projections indicate .